Prime Minister Narendra Modi interacted with the domestic vaccine manufacturers recently.
He exhorted that the country needs to institutionalise the best practices learnt during the last one and a half years, and said that this is an opportunity to modify our practices, in tune with the global standards. He also said that the entire world is looking up to India, in the backdrop of the success of the vaccination drive and the vaccine manufacturers should continuously work together to be ready to face future challenges.
The vaccine manufacturers appreciated the vision and leadership of the Prime Minister in providing continuous guidance and support towards the development of the vaccines. They also praised the never-before seen collaboration between government and industry, and applauded the regulatory reforms, simplified procedures, timely approvals, and forthcoming and supportive nature of the government throughout this endeavour.
Those present during the interaction included Adar Poonawala, CEO, Serum Institute of India, Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech; Pankaj Patel, Chairman and Managing Director, Zydus Cadila; Mahima Datla, Managing Director, Biological E; Dr Sanjay Singh, Whole-time Director and CEO, Gennova Biopharmaceuticals; Satish Reddy, Whole-time Director, Dr Reddy’s Laboratories and Dr Rajesh Jain, Joint Managing Director, Panacea Biotech, among several other people from the industry, along with some ministers.